Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics

EMBO Journal

Volumn 20, Issue 16, 2001, Pages 4432-4442

  Cross, Karen J ^a   Wharton, Stephen A ^a   Skehel, John J ^a   Wiley, Don C ^b   Steinhauer, David A ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Fusion; Hemagglutinin; Influenza; Reverse genetics

Indexed keywords

ALANINE; GLYCINE; HYBRID PROTEIN; INFLUENZA VIRUS HEMAGGLUTININ; LEUCINE; MUTANT PROTEIN; PHENYLALANINE; SERINE; VALINE; VIRUS FUSION PROTEIN;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CONFORMATIONAL TRANSITION; HUMAN; HUMAN CELL; HYDROPHOBICITY; INFLUENZA VIRUS; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; REVERTANT; VIRAL GENETICS; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS REPLICATION;

ACIDS; ANIMALS; CELL LINE; CELL LINE, TRANSFORMED; CELL MEMBRANE; CRICETINAE; DOGS; GENE EXPRESSION; HELA CELLS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; MEMBRANE FUSION; MUTAGENESIS; PEPTIDES; PROTEIN CONFORMATION; PROTEIN PRECURSORS;

INFLUENZA VIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0035881708     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.16.4432     Document Type: Article

References (62)

1. Structural basis for paramyxovirus-mediated membrane fusion
2. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody
3. Selection of recombinant vaccinia viruses on the basis of plaque formation
4. Structure of influenza haemagglutinin at the pH of membrane fusion
5. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41
6. Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies
7. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation
8. 2 subunit to form an N cap that terminates the triple-stranded coiled-coil
9. The transmembrane domain in viral fusion: Essential role for a conserved glycine residue in vesicular stomatitis virus G protein
10. Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion
11. Fusion mutants of the influenza virus hemagglutinin glycoprotein
12. A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range
13. Structure of an analog of fusion peptide from hemagglutinin
14. Delivery of macromolecules into cells expressing a viral membrane fusion protein
15. Retrovirus envelope domain at 1.7 angstrom resolution
16. Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage
17. 2-terminal sequence generated during precursor activation
18. Studies on the mechanism of membrane fusion: Site-specific mutagenesis of the hemagglutinin of influenza virus
19. Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity
20. Effect of the N-terminal glycine on the secondary structure, orientation and interaction of the influenza hemagglutinin fusion peptide with lipid bilayers
21. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion
22. Activation of influenza A viruses by trypsin treatment
23. Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore
24. Sequential mutations in hemagglutinins of influenza B virus isolates: Definition of antigenic domains
25. Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide
26. 2 terminus of influenza HA-2
27. Adaptation of egg-grown and transfectant influenza viruses for growth in mammalian cells: Selection of hemagglutinin mutants with elevated pH of membrane fusion
28. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-Å resolution
29. The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores
30. Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion
31. Kinetics of pH-dependent fusion between 3T3 fibroblasts expressing influenza hemagglutinin and red blood cells. Measurement by dequenching of fluorescence
32. Generation of influenza A viruses entirely from cloned cDNAs
33. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses
34. Influence of membrane anchoring and cytoplasmic domains on the fusogenic activity of vesicular stomatitis virus glycoprotein G
35. Thermolysin activation mutants with changes in the fusogenic region of an influenza virus hemagglutinin
36. Mutations in the membrane-spanning domain of the human immunodeficiency virus envelope glycoprotein that affect fusion activity
37. Helical membrane protein folding, stability and evolution
38. A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype
39. Heterologous transmembrane and cytoplasmic domains direct functional chimeric influenza virus hemagglutinins into the endocytic pathway
40. Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes
41. Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion
42. Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses
43. Studies on the primary structure of the influenza virus hemagglutinin
44. Coiled-coils in both intracellular vesicle and viral membrane fusion
45. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin
46. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion
47. Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: Evidence for virus-specific regulation of the pH of glycoprotein transport vesicles
48. Deacylation of the hemagglutinin of influenza A/Aichi/2/68 has no effect on membrane fusion properties
49. Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin
50. Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution
51. The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion
52. Importance of conserved amino acids at the cleavage site of the haemagglutinin of a virulent avian influenza A virus
53. The structure of a membrane fusion mutant of the influenza virus haemagglutinin
54. Atomic structure of the ectodomain from HIV-1 gp41
55. The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled-coil
56. Studies of influenza haemagglutinin-mediated membrane fusion
57. Membrane fusion by peptide analogues of influenza virus haemagglutinin
58. Viral and cellular membrane fusion proteins
59. Membrane fusion: The influenza paradigm
60. Glycoprotein incorporation and HIV-1 infectivity despite exchange of the gp160 membrane-spanning domain
61. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution
62. Structural characterization of the human respiratory syncytial virus fusion protein core